Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Harvard University

BioPhotonics
Oct 2007
In other news, Harvard University’s Office of Technology Development and Carl Zeiss MicroImaging GmbH, a 100 percent subsidiary of Carl Zeiss AG, have signed a licensing agreement permitting Zeiss to use the coherent anti-stokes Raman-scattering microscopy technology developed at Harvard in its confocal and multiphoton microscopes. This will make it possible to image biochemically important molecules in living cells and organisms without the need to label them with a dye. When combined with fluorescence imaging of biological and technical specimens, the technique will contribute to a more in-depth understanding of biological and biochemical processes. It also may be used for testing new active ingredients in the pharmaceutical industry or for medical diagnostics.

BiophotonicsCarl Zeiss MicroImaging GmbHHarvard UniversityMicroscopyNews & Features

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.